Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairment.
暂无分享,去创建一个
Tomoaki Hasui | M. Corsi | H. Kakei | E. Bettini | A. Ugolini | T. Imaeda | Tohru Yamashita | Minoru Nakamura | S. Hashizume | Atsutoshi Okabe | Takafumi Yukawa | Masaki Daini | A. Harada | Kosuke Nakashima | Naohiro Narita
[1] Yuanyuan Li,et al. Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators , 2022, Cellular and Molecular Neurobiology.
[2] Tomoaki Hasui,et al. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity. , 2021, Bioorganic & medicinal chemistry.
[3] Zhongjun Li,et al. Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models. , 2021, Journal of medicinal chemistry.
[4] A. Adell. Brain NMDA Receptors in Schizophrenia and Depression , 2020, Biomolecules.
[5] K. Roche,et al. Regulation of NMDA glutamate receptor functions by the GluN2 subunits , 2020, Journal of neurochemistry.
[6] L. Wollmuth,et al. Structure, function, and allosteric modulation of NMDA receptors , 2018, The Journal of general physiology.
[7] S. Sogabe,et al. HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production , 2018, The Journal of Pharmacology and Experimental Therapeutics.
[8] D. Jane,et al. Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action. , 2018, Journal of medicinal chemistry.
[9] Benjamin D. Sellers,et al. GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile. , 2017, ACS medicinal chemistry letters.
[10] Benjamin D. Sellers,et al. Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design. , 2016, Journal of medicinal chemistry.
[11] Daniel H. Mathalon,et al. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain , 2015, Proceedings of the National Academy of Sciences.
[12] Qiang Zhou,et al. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.
[13] R. Dingledine,et al. Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.
[14] Ehud Y Isacoff,et al. Rules of engagement for NMDA receptor subunits , 2008, Proceedings of the National Academy of Sciences.
[15] M. Segal,et al. Hippocampal Synaptic Plasticity in Mice Overexpressing an Embryonic Subunit of the NMDA Receptor , 1998, The Journal of Neuroscience.
[16] K. Williams,et al. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro , 1993, Neuron.
[17] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[18] D. Hackos,et al. Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences , 2017, Neuropharmacology.